Differential effects of two different routes of immunization on protection against gram-negative sepsis by a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine in a burned mouse model

Journal of Burn Care and Rehabilitation

Volumn 23, Issue 5, 2002, Pages 333-340

  Neely, Alice N ^a   Bhattacharjee, Apurba K ^a   Babcock, George F ^a   Holder, Ian A ^a   Cross, Alan S ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN SUBCLASS; LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN; SODIUM CHLORIDE; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BURN; CONTROLLED STUDY; DETOXIFICATION; DRUG ADMINISTRATION ROUTE; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; GRAM NEGATIVE SEPSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROVOCATION TEST; SURVIVAL RATE;

EID: 0036716941     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-200209000-00006     Document Type: Article

References (34)

1. Bacteriology of burns
2. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-June 2001, issued August 2001
3. An outbreak of extended-spectrum, β-lactamase-producing Salmonella senftenberg in a burns ward
4. Escherichia coli: Epidemiology and analysis of risk factors for infections caused by resistant strain
5. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection
6. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase
7. Pathogenesis of disseminated intravascular coagulation in sepsis
8. Disseminated intravascular coagulation
9. Therapeutic intervention in sepsis with antibody to endotoxin: Is there a future?
10. Evidence against the hypothesis that antibodies to the inner core of lipopolysaccharides in antisera raised by immunization with enterobacterial deep-rough mutants confer broad-spectrum protection during Gram-negative bacterial sepsis
11. Re. Evidence against the hypothesis that antibodies to the inner core of lipopolysaccharides in antisera raised by immunization with enterobacterial deep-rough mutants confer broad-spectrum protection during Gram-negative bacterial sepsis
12. Antiendotoxin strategies
13. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis group B outer membrane protein produces protective antibodies against gram-negative bacteremia
14. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis
15. A murine model with aspects of clinical relevance for the study of antibiotic-induced endotoxin release in septic hosts
16. The immune response to influenza virus I. Effect of the route and schedule of vaccination on the time course of the immune response, as measured by three serological methods
17. Features of cross protection between Sindbis and Venezuelan equine encephalitis viruses in mice-relationship of route of immunization to protection
18. Responses of mice immunized with influenza virus by aerosol and parenteral routes
19. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: Effective dose, time, route, and number of vaccinations
20. Studies on route of immunization with a mixture of killed parasites and adjuvants against Babesia rodhaini infection in mice
21. The route of immunization of gerbils with live Besnoitia besnoiti as a factor in protection against lethal challenge
22. Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients
23. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation
24. Immune response following genetic immunization with DNA encoding type B flagellin from Pseudomonas aeruginosa
25. Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (dLPS)/group B meningococcal outer membrane complex (OMP) in human subjects
26. Experimental studies of the pathogenesis of Pseudomonas aeruginosa infection: Description of a burned mouse model
27. Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis
28. Rapid whole-blood microassay using flow cytometry for measuring neutrophil phagocytosis
29. Virulence of Pseudomonas infection in burned rats and mice
30. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
31. Two types of murine helper T cell clones I. Definition according to profiles of lymphokine activities and secreted proteins
32. Transcutaneous immunization: A human vaccine delivery strategy using a patch
33. Dendritic cells as vectors